María Tello Lafoz

María Tello Lafoz, PhD, is a Scientist II at Immunai since November 2022, focusing on T cell therapeutics. Prior to this, María served as a Postdoctoral Scientist at Memorial Sloan Kettering Cancer Center from February 2017 to November 2022 in Morgan Huse's laboratory, where significant research included identifying a novel biophysical form of immunosurveillance that enhances cancer cell vulnerability to immune cells, published in Immunity in 2021. María held positions as a Review Editor for Cell and Developmental Biology at Frontiers and completed graduate research at the National Center for Biotechnology-CSIC, where notable achievements included elucidating protein transport mechanisms in lymphocytes and cancer cells. Internships at various prestigious institutions further augmented research expertise in cancer biology and immunology. María's educational background includes a PhD in Molecular Biosciences, a Master’s in Molecular Biomedicine, and a Bachelor’s in Biotechnology from leading Spanish universities.